Chronic Spontaneous Urticaria Clinical Trials in Guangzhou, Guangdong
4 recruitingGuangzhou, Guangdong, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals100 enrolled65 locationsNCT05677451
Recruiting
Phase 2Phase 3
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria (CSU)
Beijing InnoCare Pharma Tech Co., Ltd.344 enrolled30 locationsNCT07378527
Recruiting
Phase 2
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
Chronic Spontaneous Urticaria (CSU)Allergic Diseases
Yuhan Corporation150 enrolled30 locationsNCT07415551
Recruiting
Phase 2
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Chronic Spontaneous Urticaria
Pfizer200 enrolled52 locationsNCT07219615